Excipient effects on gastrointestinal transit and drug absorption in beagle dogs.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  International journal of pharmaceutics

• Publication date

  2005-08-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.IJPHARM.2005.05.004PMID 15979264
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Companion animal physiology and dosage form performance.

  2004cited by this paper
• The Effect of Oleic Acid on the Human Ileal Brake and Its Implications for Small Intestinal Transit of Tablet Formulations

  2004cited by this paper
• Solubilizing Excipients in Oral and Injectable Formulations

  2004cited by this paper
• Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats.

  2003cited by this paper
• Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol: in vitro and in vivo evaluation.

  2003cited by this paper
• Concentration-Dependent Effects of Polyethylene Glycol 400 on Gastrointestinal Transit and Drug Absorption

  2003cited by this paper
• Evaluation of the in‐vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products

  2002cited by this paper
• Absorption Enhancing Effect of Labrasol on the Intestinal Absorption of Insulin in Rats

  2002cited by this paper
• In vitro and in situ evidence for the contribution of Labrasol and Gelucire 44/14 on transport of cephalexin and cefoperazone by rat intestine.

  2002cited by this paper
• Influence of Polyethylene Glycol 400 on the Gastrointestinal Absorption of Ranitidine

  2002cited by this paper
• The Effect of Polyethylene Glycol 400 on Gastrointestinal Transit: Implications for the Formulation of Poorly-Water Soluble Drugs

  2001cited by this paper
• A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin.

  2001cited by this paper
• Membrane transporters.

  2000cited by this paper
• Does the site of intestinal delivery of oleic acid alter the ileal brake response?

  2000cited by this paper
• Evaluation of Using Dog as an Animal Model to Study the Fraction of Oral Dose Absorbed of 43 Drugs in Humans

  2000cited by this paper
• Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS).

  1999cited by this paper
• Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)

  1999cited by this paper
• Absorption behavior of orally administered drugs in rats treated with propantheline.

  1998cited by this paper
• Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and D-peptides.

  1998cited by this paper
• Membrane transport of drugs in different regions of the intestinal tract of the rat.

  1998cited by this paper
• The Description of the Gastrointestinal Transit of Pellets Assessed by Gamma Scintigraphy Using Statistical Moments

  1995cited by this paper
• Effect of ileal oleate on interdigestive intestinal motility of the dog

  1994cited by this paper
• Determination of ampicillin in human plasma by high-performance liquid chromatography using ultraviolet detection.

  1993cited by this paper
• C) Means to enhance penetration

  1992cited by this paper
• Characterization of the oral absorption of several aminopenicillins: determination of intrinsic membrane absorption parameters in the rat intestine in situ.

  1992cited by this paper
• Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse laplace transform (FILT)

  1989cited by this paper
• On the antipyrine test in laboratory animals. Studies in the dog and monkey.

  1989cited by this paper
• Uptake of intact TPGS (d-alpha-tocopheryl polyethylene glycol 1000 succinate) a water-miscible form of vitamin E by human cells in vitro.

  1988cited by this paper
• Gastric emptying of liquids in the fasted dog

  1988cited by this paper
• Comparison of Canine and Human Gastrointestinal Physiology

  1986cited by this paper

• Pharmaceutical excipients that alter intestinal drug Absorption: A systematic review of Excipient–Drug interactions

  2026cites this paper
• Pharmacokinetics of bromoform in dairy heifers

  2024cites this paper
• Boosting drug bioavailability in men but not women through the action of an excipient.

  2020cites this paper
• Safety and Biopharmaceutical Challenges of Excipients in Off-Label Pediatric Formulations

  2020cites this paper
• Boosting drug bioavailability in men but not women through the action of 1 an excipient 2 3

  2020cites this paper
• Sex-Dependence in the Effect of Pharmaceutical Excipients: Polyoxyethylated Solubilising Excipients Increase Oral Drug Bioavailability in Male but Not Female Rats

  2019cites this paper
• 3D printed medicines: A new branch of digital healthcare

  2018cites this paper
• An animal's sex influences the effects of the excipient PEG 400 on the intestinal P‐gp protein and mRNA levels, which has implications for oral drug absorption

  2018cites this paper
• In Vitro and In Situ Absorption and Metabolism of Sesquiterpenes from Petasites hybridus Extracts

  2018cites this paper
• Oral Formulations for Preclinical Studies

  2017cites this paper
• The development and evaluation of a subcutaneous infusion delivery system based on osmotic pump control and gas drive

  2016cites this paper
• Effects of selected pharmaceutical excipients on drug permeation at different gastro-intestinal tract regions

  2016influential citation
• Polyethylene glycols in oral and parenteral formulations--A critical review.

  2015cites this paper
• Evaluation of pharmacokinetic and pharmacodynamic properties of cimicoxib in fasted and fed horses

  2015cites this paper
• Human in vivo regional intestinal permeability: quantitation using site-specific drug absorption data.

  2015cites this paper
• Comparison of Dissolution Profiles of Commercially Available Lamivudine Tablets

  2015cites this paper
• IN VIVO IMAGING FOR VALIDATION OF ORAL DOSE PERFORMANCE

  2013cites this paper
• The applications of Vitamin E TPGS in drug delivery.

  2013cites this paper
• Strategies to Address Low Drug Solubility in Discovery and Development

  2013cites this paper
• Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.

  2012cites this paper
• Challenges and Opportunities in Achieving Bioequivalence for Fixed-Dose Combination Products

  2012cites this paper
• In situ intestinal permeability and in vivo absorption characteristics of olmesartan medoxomil in self-microemulsifying drug delivery system

  2012cites this paper
• Impact of Excipient Interactions on Drug Bioavailability from Solid Dosage Forms

  2012cites this paper
• Stability of the non-ionic surfactant polysorbate 80 investigated by HPLC-MS and charged aerosol detector.

  2011cites this paper
• Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs.

  2011cites this paper
• Investigating the stability of the nonionic surfactants tocopheryl polyethylene glycol succinate and sucrose laurate by HPLC-MS, DAD, and CAD.

  2011cites this paper
• Effects of Pluronic F68 and Labrasol on the intestinal absorption and pharmacokinetics of rifampicin in rats

  2011cites this paper
• Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro.

  2011cites this paper
• The transit of dosage forms through the small intestine.

  2010cites this paper
• The utility of the minipig as an animal model in regulatory toxicology.

  2010cites this paper
• Preformulation designed to enable discovery and assess developability.

  2010cites this paper
• Soft gelatin capsules (softgels).

  2010cites this paper
• Development of novel sibutramine base-loaded solid dispersion with gelatin and HPMC: physicochemical characterization and pharmacokinetics in beagle dogs.

  2010cites this paper
• Colonic treatments and targets: issues and opportunities

  2009cites this paper
• The use of the InteliSite companion device to deliver mucoadhesive polymers to the dog colon.

  2009cites this paper
• Evaluation of the Clearance of a Sublingual Buprenorphine Spray in the Beagle Dog Using Gamma Scintigraphy

  2008cites this paper
• Gut instincts: explorations in intestinal physiology and drug delivery.

  2008cites this paper
• Physical and biological considerations for the use of nonaqueous solvents in oral bioavailability enhancement.

  2008cites this paper
• Formulation and Design of Veterinary Tablets

  2008cites this paper
• Development and application of a LC-MS/MS method for the analysis of plasma bioavailabilities of different cannabinoids after the administration of "Cannabis sativa L." extracts and MarinolTM

  2008cites this paper
• Ranitidine) in Male Subjects but Not Females

  2008cites this paper
• Polyethylene Glycol 400 Enhances the Bioavailability of a BCS Class III Drug (Ranitidine) in Male Subjects but Not Females

  2008cites this paper
• In Vivo Performance of an Oral MR Matrix Tablet Formulation in the Beagle Dog in the Fed and Fasted State: Assessment of Mechanical Weakness

  2008cites this paper
• Polymer Effects on Appetite Suppression by Lipoic Acid Nanoparticles

  2007cites this paper
• Understanding the degradation pathway of a poorly water-soluble drug formulated in PEG-400.

  2007cites this paper
• The effects of pharmaceutical excipients on drug disposition.

  2007cites this paper
• In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets.

  2006cites this paper
• Preclinical formulations for discovery and toxicology: physicochemical challenges

  2006cites this paper
• Impact of formulation excipients on human intestinal transit

  2006cites this paper